|
GB1506200A
(en)
*
|
1975-04-30 |
1978-04-05 |
Farmaceutici Italia |
Glycosides
|
|
GB1509875A
(en)
*
|
1976-06-14 |
1978-05-04 |
Farmaceutici Italia |
Optically active anthracyclinones and anthracycline glycosides
|
|
US4161480A
(en)
*
|
1978-06-05 |
1979-07-17 |
G. D. Searle & Co. |
Intermediates for the synthesis of 4-demethoxydaunorubicin
|
|
US4201773A
(en)
*
|
1978-07-26 |
1980-05-06 |
The United States Of America As Represented By The Department Of Health, Education And Welfare |
7-O-(2,6-Dideoxy-α-L-lyxo-hexopyranosyl)-daunomycinone, desmethoxy daunomycinone, adriamycinone, and carminomycinone
|
|
IL55431A
(en)
*
|
1978-08-24 |
1982-07-30 |
Yeda Res & Dev |
Anthracycline type antibiotics,their preparation and pharmaceutical compositions comprising them
|
|
NL8001417A
(nl)
*
|
1979-03-17 |
1980-09-19 |
Erba Farmitalia |
Antitumorglycosiden.
|
|
BE884828A
(fr)
*
|
1979-08-20 |
1981-02-19 |
Hoffmann La Roche |
Derives de naphtacene
|
|
CA1154013A
(en)
*
|
1979-09-01 |
1983-09-20 |
Alberto Bargiotti |
Antitumor glycosides, their preparation, use and compositions thereof
|
|
DE3100968A1
(de)
*
|
1980-01-16 |
1982-01-14 |
Farmitalia Carlo Erba S.p.A., 20159 Milano |
Anthracyclinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
|
|
US4348388A
(en)
*
|
1980-04-02 |
1982-09-07 |
G.D. Searle & Co. |
11-Amino-11-deoxydaunorubicin and analogs
|
|
ZA814722B
(en)
*
|
1980-07-18 |
1982-07-28 |
Hoffmann La Roche |
Novel anthracycline glycosides
|
|
US5138042A
(en)
*
|
1981-05-28 |
1992-08-11 |
Farmitalia Carlo Erba S.P.A. |
6-deoxyanthracyclines
|
|
IT1210476B
(it)
*
|
1981-05-28 |
1989-09-14 |
Erba Farmitalia |
Antracicline.
|
|
GB8317037D0
(en)
*
|
1983-06-23 |
1983-07-27 |
Erba Farmitalia |
6-deoxyanthracyclines
|
|
US4563444A
(en)
*
|
1982-05-26 |
1986-01-07 |
Farmitalia Carlo Erba S.P.A. |
Anthracycline glycosides, use and compositions containing same
|
|
US4604381A
(en)
*
|
1982-07-16 |
1986-08-05 |
Farmitalia Carlo Erba S.P.A. |
4-demethoxy-13-dihydrodaunorubicin and use thereof
|
|
US4562177A
(en)
*
|
1982-08-17 |
1985-12-31 |
The Ohio State University Research Foundation |
3'-Amino-2' halo-anthracycline antibiotics
|
|
US4564674A
(en)
*
|
1983-10-31 |
1986-01-14 |
Sagami Chemical Research Center |
Process for an anthracycline derivative, and an anthracyclinone derivative useful for the process
|
|
US4496485A
(en)
*
|
1983-11-25 |
1985-01-29 |
G. D. Searle & Co. |
Asymmetric 7-O-(substituted acetyl)-4-demethoxydaunomycinones
|
|
US4537882A
(en)
*
|
1984-05-10 |
1985-08-27 |
Ohio State University |
4-Demethoxy-3'-desamino-2'-halo-anthracycline and pharmaceutical composition containing same
|
|
US4697005A
(en)
*
|
1985-03-20 |
1987-09-29 |
Ohio State University Research Foundation |
1-fluoro, 4-fluoro, and 1,4-difluoro anthracycline anticancer antibiotics
|
|
US5124317A
(en)
*
|
1985-08-02 |
1992-06-23 |
Farmitalia Carlo Erba S.P.A. |
Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
|
|
NZ224252A
(en)
*
|
1987-04-21 |
1991-09-25 |
Erba Carlo Spa |
An anthracycline glycoside and its preparation
|
|
JPS63191263U
(2)
*
|
1987-05-29 |
1988-12-09 |
|
|
|
GB2212154B
(en)
*
|
1987-11-10 |
1991-03-27 |
Erba Carlo Spa |
New 4-demethoxy anthracycline derivatives
|
|
GB8803301D0
(en)
*
|
1988-02-12 |
1988-03-09 |
Erba Carlo Spa |
Process for preparation of 4-demethoxy-daunomycinone aglycone of 4-demethoxy-daunorubicin
|
|
GB8808475D0
(en)
*
|
1988-04-11 |
1988-05-11 |
Erba Carlo Spa |
Process for preparing 4-demethoxydauno-mycinone
|
|
GB8818167D0
(en)
*
|
1988-07-29 |
1988-09-01 |
Erba Carlo Spa |
Novel 4-substituted anthracyclinones & process for their preparation
|
|
DK0629209T3
(da)
*
|
1992-03-02 |
1997-10-13 |
Pfizer |
Sukkerderivater af makrolider
|
|
US8252520B2
(en)
*
|
2002-10-11 |
2012-08-28 |
Taivex Therapeutics Corporation |
Methods and compounds for inhibiting Hec1 activity for the treatment of proliferative diseases
|
|
JP5475234B2
(ja)
|
2005-01-21 |
2014-04-16 |
アステックス・セラピューティクス・リミテッド |
医薬化合物
|
|
JP5528807B2
(ja)
|
2006-10-12 |
2014-06-25 |
アステックス、セラピューティックス、リミテッド |
複合薬剤
|
|
WO2008044041A1
(en)
|
2006-10-12 |
2008-04-17 |
Astex Therapeutics Limited |
Pharmaceutical combinations
|
|
US8173621B2
(en)
|
2008-06-11 |
2012-05-08 |
Gilead Pharmasset Llc |
Nucleoside cyclicphosphates
|
|
PT2376088T
(pt)
*
|
2008-12-23 |
2017-05-02 |
Gilead Pharmasset Llc |
Fosforamidatos de nucleósidos de 2-amino-purina 6-osubstituída
|
|
SG194404A1
(en)
*
|
2008-12-23 |
2013-11-29 |
Gilead Pharmasset Llc |
Synthesis of purine nucleosides
|
|
KR20110098849A
(ko)
*
|
2008-12-23 |
2011-09-01 |
파마셋 인코포레이티드 |
뉴클레오시드 유사체
|
|
MX358013B
(es)
|
2009-11-13 |
2018-08-01 |
Amgen Inc |
Materiales y metodos para el tratamiento o prevencion de enfermedades asociadas al her-3.
|
|
PT2609923T
(pt)
|
2010-03-31 |
2017-08-30 |
Gilead Pharmasset Llc |
Processo para a cristalização de 2-(((s)- (perfluorofenoxi)(fenoxi)fosforil)amino)propanoato de (s)-isopropilo
|
|
AU2011286407A1
(en)
|
2010-08-06 |
2013-02-21 |
Amgen |
Use of HER3 binding agents in prostate treatment
|
|
DE102011113652A1
(de)
|
2011-09-19 |
2013-03-21 |
Heraeus Precious Metals Gmbh & Co. Kg |
Kristallisierung von Idarubicinhydrochlorid
|
|
US10047116B2
(en)
|
2011-10-03 |
2018-08-14 |
Mx Adjuvac Ab |
Nanoparticles, process for preparation and use thereof as carrier for amphipatic and hydrophobic molecules in fields of medicine including cancer treatment and food related compounds
|
|
US9907846B2
(en)
|
2013-04-01 |
2018-03-06 |
Mx Adjuvac Ab |
Nanoparticles, composed of sterol and saponin from Quillaja saponaria Molina for use in pharmaceutical compositions
|
|
EP3669890A1
(en)
|
2018-12-18 |
2020-06-24 |
Croda International PLC |
Filamentous nanoparticles having vaccine adjuvant effect
|